Event-Driven Stocks

Tracon Pharmaceuticals, Inc.

TCON

Other · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 2 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY23FY22FY21FY20FY19FY18
Revenue$12.0M$0$346,000$0$0$3.0M
Operating income−$9.3M−$27.9M−$28.3M−$16.2M−$22.3M−$34.7M
Net income−$3.6M−$29.1M−$28.7M−$16.8M−$22.7M−$35.0M
Total assets$10.1M$19.5M$26.6M$37.4M$18.1M$40.6M
Total liabilities——————
Equity−$809,000−$7.2M$11.7M$25.1M$2.7M$21.4M
EPS (diluted)$-0.11$-1.39$-1.66$-1.87——
Shares out.23.8M19.6M15.5M5.4M29.9M17.7M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2023
Operating margin
−77.0%
Net margin
−29.8%
Return on equity
443.5%
Return on assets
−35.5%
Return on capital (ROCE)
—
Liabilities / assets
—
Debt / equity
—
Book value / share
$-0.03
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2023
Accruals / assets
−71.9%clean
Piotroski F-Score
5/7mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
48
/ 100
Profitability 25Growth n/aCatalyst 67Earnings quality 100Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 1 severe● 2 warning● 3 good
  • Negative shareholder equity
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Strong return on equity (>15%)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Insider transactions

SEC Form 4 · most recent
4 acquisitions1 disposals2 open-market buy(s)net −4.1M shares · last 5
InsiderDateTypeSharesPrice
Brown Scott B.Officer — CHIEF FINANCIAL OFFICERApr 20, 2023Grant3,500$0.14
Theuer CharlesOfficer — PRESIDENT AND CEOApr 20, 2023Grant3,500$0.14
Opaleye Management Inc.10% ownerNov 10, 2023Sell4.3M$0.29
Theuer CharlesOfficer — President and CEOApr 26, 2023Buy3,999$0.66
Opaleye Management Inc.10% ownerMar 9, 2023Buy174,508$1.38

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.